Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 9, 2011
Pharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory studyLara A Ray, Spencer Bujarski, Pauline F Chin, et al.
Psychopharmacology|April 14, 2011
A human laboratory study of the effects of quetiapine on subjective intoxication and alcohol cravingLara A Ray, Pauline F Chin, Andia Heydari, et al.
Expert Opinion on Drug Safety|August 23, 2005
Psychiatric symptoms associated with ephedra useMargaret Maglione, Karen Miotto, Martin Iguchi, et al.
Substance Abuse and Rehabilitation|January 30, 2014
Selective review and commentary on emerging pharmacotherapies for opioid addictionWalter Ling, Larissa Mooney, Min Zhao, et al.
Psychological Trauma : Theory, Research, Practice and Policy|June 12, 2020
Implementing an emotional support and mental health response plan for healthcare workers during the COVID-19 pandemicKaren Miotto, Jesse Sanford, Melissa J Brymer, et al.
Journal of Addiction Medicine|April 6, 2012
Comparisons of analgesic potency and side effects of buprenorphine and buprenorphine with ultra-low-dose naloxoneWalter Ling, Maureen Hillhouse, Jessica Jenkins, et al.
Drug and Alcohol Dependence|January 10, 2013
The effects of varenicline on stress-induced and cue-induced craving for cigarettesLara A Ray, Katy Lunny, Spencer Bujarski, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 17, 2017
Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory TrialLara A Ray, Spencer Bujarski, Steve Shoptaw, et al.
The American Journal of Psychiatry|December 31, 2004
Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse eventsMargaret Maglione, Karen Miotto, Martin Iguchi, et al.
Pageof 6